Literature DB >> 12670310

Migration and differentiation of neural progenitor cells from two different regions of embryonic central nervous system after transplantation into the intact spinal cord.

Mitsuhiro Enomoto1, Kenichi Shinomiya, Shigeo Okabe.   

Abstract

Transplantation of in vitro-expanded neural stem cells (NSCs) is a potentially powerful tool to repair functions of the injured spinal cord. A prerequisite for the successful transplantation therapy is identification of optimized experimental parameters that can promote maximal survival, extensive migration and selective differentiation of the transplanted NSC population in the spinal cord. To this end, we evaluated the basic characteristics of NSC-like cells from two different donor sources, the embryonic hippocampus and spinal cord, after transplantation into the neonatal spinal cord. Proliferation and differentiation phenotypes of both NSC-like cells can be controlled by the concentration of fibroblast growth factor-2 (FGF-2) in vitro. Both NSC-like cells can survive within the environment of the intact neonatal spinal cord and showed extensive migratory behaviour shortly after transplantation. However, quantitative analysis revealed preferential migration of hippocampus-derived cells in the dorsal white matter. Both NSC-like cells showed restricted phenotype toward the oligodendroglial lineage after transplantation. Transplantation of the mixture of two cell types revealed selective survival of hippocampus-derived NSC-like cells. This study indicates the possibility of transplanting hippocampus-derived NSCs to supply the cell source for immature oligodendrocytes, which are thought to be essential for both the myelination and trophic support of regenerating axons in the dorsal white matter of the spinal cord.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670310     DOI: 10.1046/j.1460-9568.2003.02555.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  6 in total

1.  Neural stem cells grafts decrease neural apoptosis associated with caspase-7 downregulation and BDNF upregulation in rats following spinal cord hemisection.

Authors:  Guan-nan Xia; Yu Zou; You-cui Wang; Qing-jie Xia; Bing-tuan Lu; Ting-hua Wang; Jian-guo Qi
Journal:  Cell Mol Neurobiol       Date:  2013-08-21       Impact factor: 5.046

2.  Differential effects of distinct central nervous system regions on cell migration and axonal extension of neural precursor transplants.

Authors:  Ying Jin; Karna Sura; Itzhak Fischer
Journal:  J Neurosci Res       Date:  2012-06-27       Impact factor: 4.164

3.  Reconstitution of the central and peripheral nervous system during salamander tail regeneration.

Authors:  Levan McHedlishvili; Vladimir Mazurov; Kathrin S Grassme; Kerstin Goehler; Bernhard Robl; Akira Tazaki; Kathleen Roensch; Annett Duemmler; Elly M Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-24       Impact factor: 11.205

4.  Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord.

Authors:  Jun Yan; Leyan Xu; Annie M Welsh; Glen Hatfield; Thomas Hazel; Karl Johe; Vassilis E Koliatsos
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

5.  Secretome Analysis of Mesenchymal Stem Cell Factors Fostering Oligodendroglial Differentiation of Neural Stem Cells In Vivo.

Authors:  Iria Samper Agrelo; Jessica Schira-Heinen; Felix Beyer; Janos Groh; Christine Bütermann; Veronica Estrada; Gereon Poschmann; Ana Bribian; Janusz J Jadasz; Laura Lopez-Mascaraque; David Kremer; Rudolf Martini; Hans Werner Müller; Hans Peter Hartung; James Adjaye; Kai Stühler; Patrick Küry
Journal:  Int J Mol Sci       Date:  2020-06-18       Impact factor: 5.923

6.  Critical involvement of Rho GTPase activity in the efficient transplantation of neural stem cells into the injured spinal cord.

Authors:  Fujiki Numano; Akihiro Inoue; Mitsuhiro Enomoto; Kenichi Shinomiya; Atsushi Okawa; Shigeo Okabe
Journal:  Mol Brain       Date:  2009-11-28       Impact factor: 4.041

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.